-
About
TOGETHER WITH THE PASQUAL MARAGALL FOUNDATION, WE WORK FOR A FUTURE WITHOUT ALZHEIMER'S
-
Research
INNOVATIVE SOLUTIONS TO UNVEIL AND PREVENT NEURODEGENERATION
-
Services
CUTTING-EDGE FACILITIES AND A TEAM DEVOTED TO RESEARCH
-
Alfa Study
MORE THAN 2.700 DESCENDANTS OF people living with ALZHEIMER'S WILLING TO CHANGE HISTORY
-
Participate
YOU CAN HELP US TO CHANGE THE HISTORY OF THE DISEASE
-
News
STAY INFORMED ABOUT THE LATEST NEWS ON ALZHEIMER'S AND BRAIN RESEARCH
Latest news on Alzheimer's
Consulta las últimas noticias sobre la investigación de la enfermedad de Alzheimer que llevamos a cabo en el Barcelonaβeta Brain Research Center (BBRC). Te contamos los avances en prevención del Alzheimer en los que participan nuestros científicos, así como todas las novedades en relación con el Estudio Alfa, dedicado a la detección precoz y la prevención de la enfermedad.
What is the effect of biological –but not chronological– age, in Alzheimer’s disease?
BBRC researchers have received funding from the Alzheimer’s Association to analyze the possible effect of telomeres, which are considered a biomarker of biological aging, in the disease
Alfa and TRIBEKA join the Global Alzheimer’s Association Interactive Network
Data of the Study Alfa is now available, upon request, on the integrated online research platform launched by the Alzheimer’s Association.
UAB and IMIM publish the results of a study which used BBRC’s MRI
The neuroimaging study shows social exclusion relevant in motivating extremism in those vulnerable to radicalisation
BBRC performed 893 visits for the EPAD project in 2018
The Barcelonaβeta Brain Research Center is the top recruiter study site in Europe, with more than 200 Spanish research participants visited
BBRC researchers identify cognitive and brain volumetric profile differences in individuals with subjective cognitive decline
The study has detected that some individuals who perceive subjective cognitive decline have a worse cognitive performance and lower grey matter volumes in areas which are affected by Alzheimer’s disease
“The personal satisfaction of being part of the study is enormous”
Alejandro Laquidain is one of the more than 200 Spanish research participants of the EPAD project recruited at BBRC.
BBRC launches new study with umbilical cord blood from the Blood and Tissue Bank
The aim of the project, entitled AlfaAge, is to identify pro-ageing and pro-youthful blood biomarkers in different age groups.
José Luis Molinuevo gives the Keynote lecture of the Alzheimer Europe Conference
BBRC researchers also participate in an oral communication and two poster presentations.
BBRC researchers participate in the 11th Clinical Trials on Alzheimer’s disease
CTAD conference took place in Barcelona, from the 24th to the 27th of October.
